Analysis of 100 consecutive hepatectomies: Risk factors in patients with liver cirrhosis or obstructive jaundice

World Journal of Surgery

Volumn 25, Issue 3, 2001, Pages 266-272

  Das, B C ^a   Isaji, S ^a   Kawarada, Y ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYL HUMAN SERUM ALBUMIN TC 99M; HYALURONIC ACID; INDOCYANINE GREEN; INTERLEUKIN 6; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILIARY TRACT DRAINAGE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMIHEPATECTOMY; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; LIVER SCINTISCANNING; MALE; OBSTRUCTIVE JAUNDICE; PARTIAL HEPATECTOMY; POSTOPERATIVE COMPLICATION; RISK FACTOR; SURGICAL MORTALITY; SURGICAL STRESS; TREATMENT OUTCOME;

ADULT; AGED; CHOLESTASIS; FEMALE; HEPATECTOMY; HUMANS; HYALURONIC ACID; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0035043463     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002680020059     Document Type: Article

References (38)

1. Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma
2. High preoperative serum alanine transferase levels: Effect on the risk of liver resection in Child grade A cirrhotic patients
3. Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma
4. Aggressive surgical resection for cholangiocarcinoma
5. Treatment of hilar cholangiocarcinoma (Klatskin tumor) with hepatic resection or transplantation
6. Metabolic abnormalities associated with postoperative organ failure: A redox theory
7. Determination of the hepatic elimination capacity of galactose by single injection
8. Determination of serum antipyrine half-lives in patients with liver disease
9. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma: Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma
10. Serum hyaluronate in liver diseases: Study by enzymoimmunological assay
11. Serum marker for hepatic fibrosis and related liver pathology
12. Serum laminin and hyaluronan in liver cirrhosis: Markers of progression with high prognostic value
13. Hyaluronic acid uptake by the isolated perfused rat liver: An index of hepatic sinusoidal endothelial cell function
14. Gram-negative bacterial lipopolysaccharide impairs hyaluronan clearance in vivo and its uptake by isolated perfused rat liver
15. 3H]hyaluronan injected subcutaneously in rabbits
16. Criteria for safe hepatic resection
17. S4a + S5 with caudate lobe (S1) resection using Taj Mahal parenchymal resection for carcinoma of the biliary tract
18. Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented?
19. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin
20. Assay of serum hyaluronic acid clinical application
21. Postoperative changes in resting energy expenditure and interleukin 6 level in infants
22. An enzyme-linked immunosorbent assay for the measurement of human interleukin-6
23. A multiple regression equation for prediction of posthepatectomy liver failure
24. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus
25. Outcome of extended right hepatectomy after biliary drainage in hilar bile duct cancer
26. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function
27. A new liver functional study using Tc-99m DTPA-galactosyl human serum albumin: Evaluation of the validity of several functional parameters
28. Prediction of postoperative decompensated liver function by technetium 99m galactosyl human serum albumin liver scintigraphy in patients with hepatocellular carcinoma complicating chronic liver disease
29. Serum levels of hyaluronic acid during the perioperative period of hepatic resection
30. Logistic regression and discriminate analyses of hepatic failure after liver resection for carcinoma of the biliary tract
31. Increased serum interleukin-6 levels and reduction of hepatic acute phase response after major hepatectomy
32. Hyperactive cytokine response after partial hepatectomy in patients with biliary obstruction
33. Tumor necrosis factor-α produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation
34. Indications and outcome of hepatopancreatoduodenectomy in the treatment of carcinoma of the gallbladder
35. Simultaneous extensive resection of the liver and the pancreas in dogs
36. Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable tumors
37. Intraarterial chemotherapy with Lipiodol for initially unresectable hepatoblastomas in children
38. Alteration in levels of human hepatocyte growth factor following hepatectomy